FDA Clearance Tracker · P850010
HELISTAT(TM) ABSORBABLE COLLAGEN HEMOSTATIC SPONGE
Last checked: Nov 20, 2026Latest source record: Nov 8, 1985 (this decision)Source: openFDAMethods & limitations
Decided
Nov 8, 1985
Approved
Time to decision
261 days
Received Feb 20, 1985. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P850010
- Device name
- HELISTAT(TM) ABSORBABLE COLLAGEN HEMOSTATIC SPONGE
- Applicant
- Integra LifeSciences Corporation
- Applicant location
- Plainsboro, NJ
- Received
- Feb 20, 1985
- Decided
- Nov 8, 1985
- Decision
- Approved
- Supplements
- 113 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LMF. The earliest in FDA's data is N17600, decided Aug 26, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Integra LifeSciences Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251162 · Decided Oct 8, 2025 · 176 days after receipt
Device type: Instrument, Ultrasonic Surgical (LFL) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.